New Tools for Science Policy
Public Funding, Patents, and Technology Transfer: Learning from the Contrasting Oxford and Texas Models of COVID-19 Vaccine Production and Distribution
About the Seminar
April 29, 2024 9:00am—10:00am
The COVID-19 pandemic spurred substantial debate over how to rapidly develop new vaccines, produce billions of doses, and distribute them globally. Central to these debates are the roles of intellectual property, technology transfer, and public funding. Ken Shadlen explored these issues, drawing on the global production experiences of two publicly-funded vaccines developed in university labs: one from the University of Oxford in the UK, and the other from Baylor College of Medicine in the US. The presentation examined how the innovation ecosystem functioned during the COVID-19 pandemic and offered insights for policymakers preparing for future pandemics and other global challenges.
Links
Past Series
-
October 03, 2024 3:30pm
Carbon Removal Social [Science]
Holly Buck, Sara Nawaz, Rory Jacobson, Marcela Mulholland, Amanda Borth
-
December 15, 2023 9:00am
Responsible Artificial Intelligence: Policy Pathways to a Positive AI Future
Andrew Maynard
-
November 17, 2023 9:00am
“Unacceptable Costs”: Managing for biological invasions and climate risks in the US Pacific Islands
Laura Brewington
-
October 30, 2023 9:00am
Patent Data & Publicly-Funded Research: Applications, Benefits, & Misuse
Bhaven N. Sampat
-
April 05, 2023 9:00am
Quantity over Quality: How to Solve Electric Vehicle Charging Infrastructure
Ryan Cornell
-
March 29, 2023 9:00am
How Complexity Science Can Guide Urban Transformations
Bastian Alm, Shade Shutters
-
February 02, 2023 9:00am
Making Research Matter for Policy
Robert M Cook-Deegan
-
October 07, 2022 9:00am
Creating Justice, Trust, and Inclusivity in Climate Policymaking
Kaiping Chen
-
March 21, 2022 9:00am
Framing Our Biological Futures
Cynthia Selin, Christopher Scott, David Tomblin, Janine Myszka , Lauren Lambert, Haley Manley, Dorit Barlevy